Literature DB >> 22115801

Clinical outcomes after surgical resection of colorectal cancer in 1,294 patients.

Yanxin Luo1, Ji Cui, Chuangqi Chen, Shunxin Song, Meijin Huang, Junsheng Peng, Ping Lan, Yihua Huang, Lei Wang, Jianping Wang.   

Abstract

BACKGROUND/AIMS: This study aimed to determine the overall survival time and clinical characteristics affecting the outcomes in patients with resectable colorectal cancer (CRC).
METHODOLOGY: Clinical data from CRC patients who underwent surgical resections from 1994 to 2004 was analyzed retrospectively using the documented records and gastrointestinal tumor databases at the gastrointestinal institute. Univariate and multivariate analyses were conducted to investigate the association between clinical variables and overall survival time.
RESULTS: A consecutive series of 1.294 CRC patients were enrolled for the final analyses. The five-year survival rates were 94.1%, 80.2%, 61.7% and 23.2% of patients with stage from I to IV CRC, respectively. One hundred and seven patients (8.3%) had disease recurrence during the follow-up with a median of 50.3 months. After radical surgical resections, patients with recurrence could still expect a five-year survival rate of 44.3%. Multivariate analysis showed that patient age >60 years, infiltrative tumor type, intestinal obstruction, poor tumor differentiation, disease recurrence and late TNM stage were associated with poor survival (all p<0.05).
CONCLUSIONS: The overall postoperative survival in this series of patients with CRC was mainly affected by patient age, tumor morphology, bowel obstruction, histological grade, TNM stage and disease recurrence. For those patients with recurrence, surgical resection should be recommended primarily if the tumor is resectable.

Entities:  

Mesh:

Year:  2012        PMID: 22115801     DOI: 10.5754/hge11676

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  9 in total

1.  The predicting value of postoperative body temperature on long-term survival in patients with rectal cancer.

Authors:  Huichuan Yu; Yanxin Luo; Hui Peng; Liang Kang; Meijin Huang; Shuangling Luo; Wenhao Chen; Zihuan Yang; Jianping Wang
Journal:  Tumour Biol       Date:  2015-05-15

2.  Association between six genetic polymorphisms and colorectal cancer: a meta-analysis.

Authors:  Cheng Chen; Lingyan Wang; Qi Liao; Leiting Xu; Yi Huang; Cheng Zhang; Huadan Ye; Xuting Xu; Meng Ye; Shiwei Duan
Journal:  Genet Test Mol Biomarkers       Date:  2014-02-19

3.  Expression of deleted in liver cancer 2 in colorectal cancer and its correlation with clinicopathological parameters.

Authors:  Kai Gao; Xiaorong Li; Gui Hu; Kaiyan Yang; Buning Tian; Yi Zhang
Journal:  Oncol Lett       Date:  2012-08-06       Impact factor: 2.967

4.  Epidemiology and Survival of Colorectal Cancer in Lebanon: A Sub-National Retrospective Analysis.

Authors:  Rajaa Chatila; Joseph Mansour; Anas Mugharbil; Ghazi Nsouli; Lana O'Son; Edouard Sayad; Mary E Deeb
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

5.  AHCYL1 Is a Novel Biomarker for Predicting Prognosis and Immunotherapy Response in Colorectal Cancer.

Authors:  Xubin Li; Mengqiao Zhang; Xue Yu; Mei Xue; Xiaowei Li; Chao Ma; Wei Jia; Qiang Gao; Chunbo Kang
Journal:  J Oncol       Date:  2022-05-07       Impact factor: 4.501

6.  Epigenetic silencing of TPM2 contributes to colorectal cancer progression upon RhoA activation.

Authors:  Ji Cui; Yonghua Cai; Ying Hu; Zenghong Huang; Yanxin Luo; Andrew M Kaz; Zihuan Yang; Dianke Chen; Xinjuan Fan; William M Grady; Jianping Wang
Journal:  Tumour Biol       Date:  2016-06-23

Review 7.  Immunotherapy for gastrointestinal malignancies.

Authors:  Paul G Toomey; Nasreen A Vohra; Tomar Ghansah; Amod A Sarnaik; Shari A Pilon-Thomas
Journal:  Cancer Control       Date:  2013-01       Impact factor: 3.302

8.  Multiple gene promoter methylation and clinical stage in adjacent normal tissues: Effect on prognosis of colorectal cancer in Taiwan.

Authors:  Chih-Hsiung Hsu; Cheng-Wen Hsiao; Chien-An Sun; Wen-Chih Wu; Tsan Yang; Je-Ming Hu; Yu-Chan Liao; Chi-Hua Huang; Chao-Yang Chen; Fu-Huang Lin; Yu-Ching Chou
Journal:  Sci Rep       Date:  2020-01-10       Impact factor: 4.379

9.  Comprehensive Analysis of N6-Methyladenosine-Related lncRNA Signature for Predicting Prognosis and Immune Cell Infiltration in Patients with Colorectal Cancer.

Authors:  Zhan Zhao; Ya-Bing Yang; Xin-Yuan Li; Xu-Guang Li; Xiao-Dong Chu; Zheng-Bin Lin; Yi-Ran Zhang; Yan-Guan Guo; Hui Ding; Yun-Long Pan; Liang Wang; Jing-Hua Pan
Journal:  Dis Markers       Date:  2021-10-28       Impact factor: 3.434

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.